Weihong Wang, Nan Bu, Hailong Cao, Ning Chen, Wei Chen, Lei Cheng, Bota Cui, Lei Dai, Huiying Gao, Meng Guo, Xingxiang He, Jia Hu, Changtao Jiang, Xianzhi Jiang, J Li, Ping Li, Wei Li, Wei‐Wei Liao, Hongwei Liu, Jingmei Liu, Ling Liu, Shuang‐Jiang Liu, Xingyin Liu, Muhan Lv, Yonghui Ma, Chaoxin Man, Zheshun Pi, Qian Ren, Li-Xuan Sang, Zhihong Sun, Huayi Suo, Yan Tan, Wanyin Tao, Guangqiang Wang, Jun Wang, Liangjing Wang, Xin Wang, Xin Wang, Ye Wang, Kaichun Wu, Rina Wu, Zhen Wu, Xiang Xiao, Bin Xiang, Yang Song, Huaxi Yi, Hong‐Jeng Yu, Jun Yu, Yue Zeng, Huihong Zhai, Qixiao Zhai, Chenhong Zhang, Guohua Zhang, Jiachao Zhang, Wenyi Zhang, Fangqing Zhao, Liang Zhao, Hongwei Zhou, Lixia Zhu, Canhui Lan, Heping Zhang, Shu Zhu, Faming Zhang
The 2025 CHINAGUT Conference has assembled a panel of 63 experts (30 scientists, 26 physicians, and 7 corporate R&D personnel) collaborated in three groups to present 30 scientific recommendations to advance probiotics, live biotherapeutic products, and fecal microbiota transplantation, addressing key issues on standardization, translation, supervision, regulation, and regulatory harmonization. These interdisciplinary guidelines aim to synthesize cutting-edge knowledge and practical needs to transform microbiota-based treatments from applications into precision-driven medical solutions, and serve as reference by scientific researchers, medical educators, pharmaceutical enterprises, clinicians, food and drug administrations, policymakers, and patients.